Claficapavir
Claficapavir (A1752) is a specific nucleocapsid protein (NC) inhibitor with an IC50 around 1 μM. Claficapavir strongly binds the HIV-1 NC (Kd=20 nM) thereby inhibiting the chaperone properties of NC and leading to good antiviral activity against the HIV-1[1].
Product Specifications
CAS Number
[2055732-24-4]
Product Name Alternative
A1752
UNSPSC
12352005
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/claficapavir.html
Purity
98.75
Solubility
DMSO : 200 mg/mL (ultrasonic; warming; heat to 40°C)
Smiles
O=C(N(C(S/1)=S)CCC(O)=O)C1=C\C2=CC=C(C3=CC=C(C=C3)Cl)O2
Molecular Formula
C17H12ClNO4S2
Molecular Weight
393.86
References & Citations
[1]Kim MJ, et al. Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein. Retrovirology. 2015;12:90. Published 2015 Nov 6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HIV-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS571133-01 1 mL
Goat anti Rat IgG2c (subclass specific), conjugated with Horseradish peroxidase
Ask
View Details 
MBS571133-02 5x 1 mL
Goat anti Rat IgG2c (subclass specific), conjugated with Horseradish peroxidase
Ask
View Details GTR15352204 1 Vial
Lentiviral human EFCAB7 shRNA (UAS) - Lentiviral human EFCAB7 shRNA (UAS, RFP) plasmid
Ask
View Details